A blood pressure cuff detects elevated pressure inside your arteries. Hypertension lab tests serve a different purpose: they may help reveal whether high blood pressure is affecting your kidneys, whether diabetes or abnormal cholesterol is increasing your cardiovascular risk, whether medications are changing your electrolytes, and whether an underlying kidney or hormonal condition may be contributing.
High blood pressure is often silent. You can feel well while pressure gradually affects the heart, brain, blood vessels, kidneys, and eyes. That is why accurate blood pressure measurement and focused laboratory testing are complementary rather than interchangeable.
Ulta Lab Tests provides access to many relevant blood and urine tests that patients can order online where available. Laboratory testing is informational, however, and does not replace an examination, diagnosis, treatment plan, medication review, or professional medical advice.
Direct answer: A blood test cannot diagnose hypertension. Blood and urine testing may help identify associated kidney damage, cardiometabolic risk, electrolyte abnormalities, medication effects, and selected secondary causes after repeated blood pressure measurements find a problem.
Hypertension means that blood is repeatedly pushing against artery walls at a pressure above the recommended range. It can develop through a combination of age, genetics, kidney function, body weight, dietary patterns, physical activity, alcohol use, sleep quality, medications, and hormonal factors.
The 2025 AHA/ACC guideline uses the following adult blood pressure categories:
| Category | Systolic pressure | Diastolic pressure |
|---|---|---|
| Normal | Below 120 mm Hg | And below 80 mm Hg |
| Elevated | 120–129 mm Hg | And below 80 mm Hg |
| Stage 1 hypertension | 130–139 mm Hg | Or 80–89 mm Hg |
| Stage 2 hypertension | 140 mm Hg or higher | Or 90 mm Hg or higher |
The guideline’s overarching treatment goal is below 130/80 mm Hg for most adults, with individualized considerations for pregnancy, frailty, institutional care, and limited life expectancy. See the American Heart Association’s guideline summary.
One elevated office measurement is not usually enough to establish sustained hypertension. The U.S. Preventive Services Task Force recommends confirming elevated office readings with measurements outside the clinical setting before treatment begins, using a validated upper-arm home monitor or ambulatory blood pressure monitoring when appropriate. This helps identify sustained, white-coat, or masked hypertension. See the USPSTF hypertension screening recommendation.
Direct answer: Hypertension is persistent elevation of blood pressure. Symptoms cannot reliably confirm or exclude it, and laboratory results may be normal even when blood pressure remains too high.
High blood pressure increases stress on artery walls and makes the heart work harder. Over time, it is associated with coronary artery disease, heart failure, atrial fibrillation, stroke, cognitive decline, chronic kidney disease, and other cardiovascular complications.
Laboratory testing helps connect the blood pressure reading with the larger health pattern. For example:
This broader view matters because a lower blood pressure reading does not necessarily mean the entire cardiovascular risk pattern has improved. Glucose, cholesterol, kidney filtration, or urine albumin may still require attention.
Most people with hypertension have no specific symptoms. Headache, fatigue, dizziness, or palpitations can occur for many reasons and should not be used to determine whether blood pressure is high.
| Symptom or risk factor | What it may suggest | Related tests or evaluation |
|---|---|---|
| Repeated high home or office readings | Sustained hypertension, white-coat hypertension, or masked hypertension | Validated home monitoring or 24-hour ambulatory monitoring; baseline blood and urine tests |
| Diabetes, abdominal weight gain, or family history of diabetes | Increased cardiometabolic and kidney risk | A1C, fasting glucose, Lipid Panel, CMP, and UACR |
| Foamy urine, blood in urine, swelling, or declining kidney function | Possible albuminuria, urinary abnormality, or kidney disease | Creatinine, eGFR, UACR, urinalysis, and CMP |
| Low potassium, muscle cramps, excessive thirst, or difficult-to-control pressure | Medication effect, kidney disorder, or possible aldosterone excess | CMP or BMP, potassium, aldosterone, renin, and aldosterone-to-renin ratio |
| Palpitations, tremor, heat or cold intolerance, constipation, or unexplained weight change | Possible thyroid dysfunction | TSH followed by Free T4 when indicated |
| Loud snoring, witnessed breathing pauses, daytime sleepiness, or resistant hypertension | Possible obstructive sleep apnea | Clinician-directed sleep study; labs assess related metabolic risk but cannot diagnose sleep apnea |
| Episodic severe pressure with pounding headache, sweating, tremor, or palpitations | A rare adrenal cause may need exclusion | Clinician-directed plasma metanephrines or 24-hour urine metanephrines |
| Rashes, joint symptoms, edema, blood or protein in urine | Possible inflammatory or autoimmune kidney involvement | Urinalysis, UACR, creatinine/eGFR; ANA, anti-dsDNA, or complement tests only when indicated |
| Pregnancy or the postpartum period with abnormal readings | Possible pregnancy-related hypertension or preeclampsia | Prompt obstetric or emergency assessment; clinician-directed blood and urine testing |
A blood pressure reading above 180/120 mm Hg should be repeated after at least one minute of rest. Call 911 when a repeated reading remains above 180/120 and is accompanied by chest pain, shortness of breath, back pain, weakness, numbness, vision changes, difficulty speaking, or other new and concerning symptoms. See the American Heart Association’s emergency guidance.
Abnormal blood pressure during pregnancy or after delivery deserves prompt clinician-directed assessment rather than routine self-testing alone.
Laboratory testing may answer five important questions:
Laboratory testing cannot determine whether a person has hypertension, diagnose sleep apnea, show daily dietary sodium intake from a serum sodium result, or independently select the correct medication or treatment goal.
A focused hypertension laboratory evaluation may be worth discussing when:
Not everyone needs every available hormone, antibody, inflammatory, or adrenal test. The most useful tests are those selected to answer a defined clinical question.
The following tests are commonly considered in a focused evaluation. Their relevance depends on the person’s blood pressure pattern, medical history, medications, symptoms, and prior results.
| Test or biomarker | What it measures | Why it may matter | What high or low results may suggest | Important limitations |
|---|---|---|---|---|
| CBC with Differential and Platelets | Red cells, white cells, hemoglobin, hematocrit, and platelets | May identify anemia or another blood-cell issue contributing to fatigue or reduced exercise capacity | Low hemoglobin may indicate anemia; other abnormalities have many possible causes | Does not diagnose hypertension or identify most secondary causes |
| Comprehensive Metabolic Panel | Glucose, creatinine, electrolytes, calcium, liver-related markers, and proteins | Provides kidney, electrolyte, glucose, liver, and medication-safety context | High creatinine, abnormal potassium, or high glucose may require follow-up | One result does not establish chronic disease; serum sodium does not measure dietary salt intake |
| Creatinine and eGFR | Creatinine is a waste product; eGFR estimates kidney filtration | Hypertension may cause or result from impaired kidney function | Rising creatinine or falling eGFR may suggest reduced filtration | Muscle mass, age, diet, hydration, acute illness, and medications may affect results |
| Urine albumin-to-creatinine ratio | Compares urine albumin with urine creatinine | Detects albumin leakage and may reveal kidney damage even when eGFR remains relatively preserved | Higher UACR suggests greater albuminuria and kidney or cardiovascular risk | Exercise, fever, infection, bleeding, dehydration, acute illness, or heart-failure exacerbation may temporarily elevate it |
| Urinalysis Complete | Urine protein, blood, glucose, cells, and other physical or chemical findings | May uncover urinary abnormalities that justify kidney or infection evaluation | Blood, protein, glucose, or abnormal cells may require additional testing | A dipstick urinalysis is not a substitute for quantitative UACR |
| Hemoglobin A1C or fasting glucose | A1C estimates average glucose exposure over roughly two to three months; glucose is a current measurement | Diabetes and hypertension frequently occur together and increase kidney and cardiovascular risk | Higher results may indicate impaired glucose regulation | Fasting requirements differ; anemia, hemoglobin variants, pregnancy, or recent blood loss may affect A1C |
| Lipid Panel | Total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides | Helps assess atherosclerotic cardiovascular risk alongside blood pressure | Higher LDL or triglycerides and lower HDL may increase risk depending on the overall pattern | Results must be interpreted with age, medical history, medications, and calculated risk |
| Apolipoprotein B | Estimates the number of atherogenic lipoprotein particles | May add risk information when triglycerides are high or lipid results are discordant | Higher ApoB generally indicates more atherogenic particles | It is not necessary for every person with hypertension |
| TSH with Free T4 when indicated | Evaluates thyroid signaling and circulating free thyroxine | Thyroid dysfunction may affect heart rate, cholesterol, body weight, and blood pressure | High or low TSH must be interpreted with Free T4 and clinical context | Pregnancy, acute illness, medications, supplements such as biotin, and laboratory methods may affect results |
| Test | Why it may be considered | General result pattern | Important limitations |
|---|---|---|---|
| Aldosterone, renin, aldosterone-to-renin ratio, and potassium | Screens for primary aldosteronism, especially when hypertension is resistant, stage 2, associated with sleep apnea, or accompanied by abnormal potassium | Inappropriately high aldosterone with suppressed renin and an elevated ratio may be a positive screening pattern | Medication classes, dietary sodium, potassium, posture, collection time, assay method, kidney function, and other conditions can substantially alter results |
| Magnesium and calcium | May add context when cramps, arrhythmias, kidney concerns, diuretic use, or other electrolyte abnormalities are present | High or low results may reflect medication, kidney, gastrointestinal, parathyroid, or nutritional factors | Neither test routinely identifies the cause of uncomplicated hypertension |
| Plasma metanephrines or 24-hour urine metanephrines | May be appropriate for episodic hypertension with headaches, sweating, tremor, or palpitations | Elevated results require careful confirmation and specialist evaluation | Stress, medicines, collection conditions, and several other factors may produce false-positive results |
| Cortisol Total Test | Reserved for a convincing pattern such as unusual bruising, purple stretch marks, muscle weakness, or other features of cortisol excess | An abnormal screening pattern may prompt endocrinology evaluation | Random cortisol testing is generally not an appropriate wellness screen |
| ANA, anti-dsDNA, or complement tests | May be considered when abnormal urine findings occur with rashes, joint symptoms, swelling, or systemic inflammation | Positive or abnormal results require interpretation with symptoms and other findings | Broad autoimmune screening is not routine for uncomplicated hypertension |
The 2025 hypertension guideline changed urine albumin-to-creatinine ratio from an optional test to part of the recommended initial evaluation for people with high blood pressure. UACR may detect albumin leakage even when creatinine and eGFR appear relatively normal. See the American College of Cardiology guideline overview.
The National Kidney Foundation generally describes:
A single abnormal UACR does not automatically establish chronic kidney disease. The result often needs to be repeated because intense exercise, infection, urinary bleeding, fever, dehydration, marked changes in blood pressure or glucose, and acute illness may temporarily elevate urine albumin. See the National Kidney Foundation’s UACR guidance.
Direct answer: UACR can reveal albumin leakage from the kidneys before a major change appears in eGFR. Because temporary factors can elevate it, one abnormal result should generally be confirmed.
Primary aldosteronism occurs when one or both adrenal glands produce too much aldosterone. Excess aldosterone promotes sodium retention, blood-volume expansion, high blood pressure, and—in some people—low potassium.
The 2025 Endocrine Society guideline conditionally suggests screening all individuals with hypertension using aldosterone, renin, an aldosterone-to-renin ratio, and potassium to support interpretation. The recommendation is conditional because feasibility, assay performance, false-positive results, resources, and collection conditions matter. See the Endocrine Society primary aldosteronism guideline.
The 2025 AHA/ACC guideline uses a more targeted approach. It recommends screening in resistant hypertension and broadens consideration to groups including adults with stage 2 hypertension and obstructive sleep apnea.
Importantly, many people with primary aldosteronism do not have obvious low potassium. A normal potassium result therefore does not rule it out.
Patients should not stop diuretics, ACE inhibitors, ARBs, beta blockers, mineralocorticoid receptor antagonists, or other blood pressure medicines independently before testing. Medication management and result interpretation should be coordinated with a qualified clinician.
For confirmed or repeatedly elevated blood pressure, a practical baseline may include:
These tests assess common associated risks and provide a safety baseline. They do not establish the cause of every case of hypertension.
Aldosterone, renin, aldosterone-to-renin ratio, and potassium may be discussed when:
The Endocrine Society’s broader screening suggestion should be balanced with test availability, medication interference, collection requirements, and the likelihood that abnormal results can receive appropriate follow-up.
Additional testing should follow the clinical pattern rather than be ordered as an indiscriminate panel. Examples include:
Blood testing cannot diagnose obstructive sleep apnea, and broad hormone or autoimmune panels are rarely the best first step.
Retesting may include:
The schedule should be individualized. Newly abnormal or changing results may require closer follow-up than stable findings.
Reference ranges can vary with the laboratory, assay, specimen type, units, age, sex, and pregnancy status. Compare each result with the range printed on that specific report.
There is no single universally accepted “optimal” range for most hypertension-related biomarkers. Clinical interpretation should prioritize validated reference intervals, guideline thresholds, personal risk factors, and trends rather than unsupported functional or wellness cutoffs.
Creatinine and eGFR should be reviewed with UACR and urinalysis. Potassium should be interpreted with kidney function and medications. Aldosterone should be reviewed with renin, potassium, posture, collection timing, and assay-specific thresholds.
Hydration, fasting, recent exercise, acute illness, infection, supplements, pregnancy, menstrual or urinary bleeding, and medication use can change results. Intense exercise may temporarily increase UACR.
Normal kidney, glucose, lipid, thyroid, and electrolyte results do not rule out hypertension. Normal creatinine does not exclude albuminuria, and normal potassium does not exclude primary aldosteronism.
An unexpected abnormality may need confirmation. A repeated result helps distinguish persistent dysfunction from temporary illness, collection conditions, laboratory variation, or short-term physiological stress.
Ulta Lab Tests allows patients to order many blood and urine tests directly online where available. Patients can review available tests and transparent prices before ordering without using insurance.
Specimen collection is performed through established laboratory networks such as Quest Diagnostics where applicable. Results are delivered through a secure online account. HSA or FSA payment may be available for eligible purchases where accepted.
Direct access may make it easier to establish a baseline, follow an existing abnormality, and bring objective results to a healthcare appointment. It does not mean that every available test is necessary or that results can safely determine a medication plan without professional review.
Explore Ulta Lab Tests options related to high blood pressure.
Fasting may be requested for a fasting glucose measurement or some lipid testing situations. Hemoglobin A1C generally does not require fasting. Follow the instructions associated with the specific order.
Avoid intense exercise for approximately 24 hours before collection. Consider postponing the test during fever, infection, urinary tract infection, urinary or menstrual bleeding, acute illness, or a heart-failure flare because these conditions may cause a temporary elevation. An early-morning urine sample may be preferred, although it is not always required.
Aldosterone and renin are especially sensitive to medication effects. The Endocrine Society advises morning collection with the patient seated, potassium measured at the same time, and no deliberate dietary sodium restriction in the days before screening. Medication adjustments should be made only when a clinician determines they are safe and necessary.
Follow the collection site’s instructions and bring any required identification or laboratory paperwork. Keep a current list of prescriptions, over-the-counter medicines, vitamins, minerals, herbal products, and recent medication changes for the clinician who will interpret the results.
Use a validated upper-arm monitor. Rest quietly for at least five minutes, sit with your back supported and feet flat, support your arm at heart level, and avoid measuring immediately after exercise, caffeine, nicotine, or a stressful event. Record multiple readings over several days rather than relying on one number.
Common starting tests may include a Comprehensive Metabolic Panel, creatinine with eGFR, potassium, sodium, Hemoglobin A1C or fasting glucose, Lipid Panel, CBC, and TSH. Blood tests do not diagnose hypertension. They provide information about kidney function, electrolyte balance, diabetes risk, cholesterol, thyroid function, medication safety, and possible contributing conditions.
No. Hypertension is identified through accurate blood pressure measurements repeated over time. A validated upper-arm home monitor or ambulatory blood pressure monitor may be used to confirm an elevated office reading. Blood and urine tests help assess possible causes, associated health risks, organ effects, and treatment safety, but normal laboratory results do not rule out hypertension.
Creatinine, eGFR, urine albumin-to-creatinine ratio, and urinalysis provide complementary information. Creatinine and eGFR estimate filtration, while UACR looks for albumin leakage that may appear before eGFR falls. Urinalysis can identify blood, protein, glucose, or other abnormalities. A single abnormal result may require repeat testing before a chronic problem is confirmed.
UACR measures how much albumin is leaking into the urine relative to urine creatinine. Albuminuria may signal kidney damage and is also associated with cardiovascular risk. The 2025 hypertension guideline recommends UACR during the initial evaluation of high blood pressure. Exercise, infection, bleeding, dehydration, or acute illness may temporarily raise it, so abnormal findings often need confirmation.
Yes. Creatinine and eGFR mainly provide information about filtration. A person may have albumin leakage while eGFR remains above 60 or appears relatively preserved. That is why UACR and, when appropriate, urinalysis are considered alongside creatinine. Kidney health cannot be fully assessed from a single creatinine result.
Potassium may be affected by kidney function, dietary intake, vomiting or diarrhea, supplements, and several blood pressure medicines. Low potassium can occur with excess aldosterone, but many people with primary aldosteronism have normal potassium. Potassium therefore helps with interpretation and medication safety but is not sensitive enough to rule out a hormonal cause by itself.
The 2025 Endocrine Society guideline conditionally suggests screening all people with hypertension, while the 2025 AHA/ACC guideline prioritizes groups such as resistant hypertension and expands consideration to stage 2 hypertension and obstructive sleep apnea. Testing is sensitive to medications, potassium, sodium intake, posture, time, and assay methods, so preparation and interpretation should involve a qualified clinician.
It depends on the tests ordered. Hemoglobin A1C usually does not require fasting. A fasting glucose test does, and fasting may be requested for certain lipid evaluations. CMP, thyroid, urine, or aldosterone-renin preparation varies by purpose and laboratory protocol. Review the instructions for every test rather than assuming the entire order has the same requirements.
No. Serum sodium is tightly regulated and reflects the relationship between sodium and body water. It is not a direct measurement of dietary sodium intake. A person may consume a high-sodium diet while having a normal serum sodium result. Dietary assessment or, in selected cases, clinician-directed urine sodium testing is more relevant to sodium intake.
Ulta Lab Tests allows patients to order many kidney, metabolic, lipid, thyroid, electrolyte, and urine tests directly online where available. Aldosterone and renin testing may also be accessible. Direct ordering does not make every test appropriate for every patient. Results—especially hormonal, kidney, electrolyte, or pregnancy-related findings—should be reviewed with a qualified healthcare professional.
Retesting depends on the original result, medications, treatment changes, and overall risk. UACR may be repeated to confirm albuminuria. Creatinine and potassium may be rechecked after certain medication changes. A1C, lipids, and thyroid tests follow different schedules. The most useful monitoring plan compares relevant trends without repeating broad panels more often than clinically necessary.
Repeat a reading above 180/120 mm Hg after at least one minute. Call 911 when it remains that high and occurs with chest pain, shortness of breath, weakness, numbness, vision changes, difficulty speaking, or another new and concerning symptom. A persistent reading in this range without symptoms still requires prompt contact with a healthcare professional.
A blood pressure cuff identifies the pressure problem. Hypertension lab tests help investigate its consequences, associated risks, possible contributors, and the safest way to monitor care.
A practical evaluation often begins with kidney function, electrolytes, UACR, urinalysis, glucose, cholesterol, CBC, and thyroid testing. Aldosterone and renin may add important information when primary aldosteronism screening is appropriate. More specialized adrenal, autoimmune, or kidney testing should follow the clinical pattern rather than be ordered routinely.
Through Ulta Lab Tests, patients can explore relevant high blood pressure, kidney, metabolic, electrolyte, thyroid, and hormone testing options online where available. Use the results to support a more informed conversation with a qualified healthcare provider, and never start, stop, or change medication solely because of a direct-access laboratory result.
Explore hypertension-related lab testing at UltaLabTests.com.
Hypertension is persistent elevation of blood pressure identified through accurate cuff measurements, not a blood test. Hypertension lab tests may reveal kidney damage, cardiometabolic risk, electrolyte abnormalities, medication effects, thyroid dysfunction, or selected secondary causes such as primary aldosteronism.
Related tests: CBC, CMP or BMP, creatinine with eGFR, UACR, urinalysis, A1C, fasting glucose, Lipid Panel, ApoB, TSH, Free T4, aldosterone, renin, aldosterone-to-renin ratio, potassium, sodium, plasma metanephrines, 24-hour urine metanephrines, cortisol, ANA, anti-dsDNA, and complement tests.
How Ulta Lab Tests helps: Patients can order many relevant blood and urine tests online where available, review transparent pricing, complete collection through established laboratory networks where applicable, and receive secure online results.
Disclaimer: Laboratory testing is informational and should be interpreted with a qualified healthcare provider alongside blood pressure measurements, symptoms, medications, medical history, pregnancy status, and cardiovascular risk.
The foundational, kidney, and urine product destinations are supported by current Ulta pages for CBC, CMP, BMP, creatinine, urine albumin-to-creatinine ratio, and complete urinalysis testing.
These tests support the article’s cardiometabolic discussion by connecting hypertension with blood sugar, diabetes risk, cholesterol, triglycerides, and atherogenic lipoprotein particles.
The individual TSH and Free T4 tests and the combined TSH and Free T4 test are alternative testing formats. The article should not imply that a patient routinely needs all three.
Potassium, sodium, and calcium may already be included in a CMP or BMP. The individual links are appropriate when the article names the biomarkers, but duplicate ordering should not be implied.
The aldosterone-renin ratio product measures the principal screening relationship discussed in the article. Medication use, potassium status, dietary sodium, posture, timing, and collection conditions may affect interpretation, so this section should preserve the article’s clinician-review language.
These are symptom-directed tests for selected clinical patterns. They should not be positioned as routine wellness tests or standard tests for uncomplicated hypertension.
These tests are most relevant when hypertension occurs with findings such as blood or protein in the urine, declining kidney function, swelling, rashes, joint symptoms, or other evidence suggesting an inflammatory or autoimmune process. Broad autoimmune testing is not a routine first step for uncomplicated hypertension.
These destinations correspond to Ulta Lab Tests’ current high blood pressure, heart, kidney, diabetes, metabolic syndrome, and cholesterol health areas.
These supporting areas align with the article’s discussion of thyroid function, aldosterone and renin, electrolytes, metabolic panels, and general health baselines.
Autoimmune, adrenal, pregnancy-related, and performance testing should remain contextual rather than being presented as routine testing for every person with hypertension. Pregnancy or postpartum hypertension requires prompt clinician-directed assessment, as described in the article.
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
